Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial

Thomas Gaisl, Protazy Rejmer, Sira Thiel, Sarah R. Haile, Martin Osswald, Malgorzata Roos, Konrad E. Bloch, John R. Stradling, Malcolm Kohler

Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Journal Issue: March
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Thomas Gaisl, Protazy Rejmer, Sira Thiel, Sarah R. Haile, Martin Osswald, Malgorzata Roos, Konrad E. Bloch, John R. Stradling, Malcolm Kohler. Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial. Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019




Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018
Year: 2018



A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial
Source: ERJ Open Res, 6 (2) 00161-2020; 10.1183/23120541.00161-2020
Year: 2020



A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate deficiency in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Long-term efficacy of motivational interviewing on improving continuous positive airway pressure adherence in obstructive sleep apnea: A randomized controlled trial
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Source: Eur Respir J 2013; 42: 1244-1254
Year: 2013



CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011

Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS.
Source: International Congress 2017 – CPAP therapy
Year: 2017


Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007